AURO VACCINES LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2021-11-08
- Employees
- 11
- Market Cap
- -
- Website
- https://aurovaccines.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety and Immunogenicity of a Nipah Virus Vaccine
Phase 1
Completed
- Conditions
- Nipah Virus Infection
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Auro Vaccines LLC
- Target Recruit Count
- 192
- Registration Number
- NCT04199169
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, United States
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Ebola Virus Disease
- First Posted Date
- 2016-03-24
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Auro Vaccines LLC
- Target Recruit Count
- 38
- Registration Number
- NCT02718469
- Locations
- 🇺🇸
Optimal Research, Melbourne, Florida, United States
News
No news found